tiprankstipranks
Advertisement
Advertisement

PCXELTI Stock Latest News

Xeltis Highlights Decade-Long Research Milestone in Supramolecular Polymer Technology
Private CompaniesXeltis Highlights Decade-Long Research Milestone in Supramolecular Polymer Technology
11h ago
XELTI
Xeltis Expands U.S. Pivotal Trial Sites as It Prepares aXess European Launch
PremiumPrivate Companies
Xeltis Expands U.S. Pivotal Trial Sites as It Prepares aXess European Launch
2d ago
XELTI
Xeltis Expands U.S. aXess Trial Sites as European Commercial Launch Nears
PremiumPrivate Companies
Xeltis Expands U.S. aXess Trial Sites as European Commercial Launch Nears
2d ago
XELTI
Xeltis Leadership Engages on U.S. Market Access Strategy at LSX World Congress
PremiumPrivate Companies
Xeltis Leadership Engages on U.S. Market Access Strategy at LSX World Congress
8d ago
XELTI
Xeltis Executive to Discuss U.S. Market Access Strategy at LSX World Congress
PremiumPrivate Companies
Xeltis Executive to Discuss U.S. Market Access Strategy at LSX World Congress
8d ago
XELTI
Xeltis Showcases aXess Vascular Access Conduit as Pivotal Trials Advance
PremiumPrivate CompaniesXeltis Showcases aXess Vascular Access Conduit as Pivotal Trials Advance
9d ago
XELTI
Xeltis Showcases aXess Graft as Pivotal Trials Advance Toward Commercialization
Premium
Private Companies
Xeltis Showcases aXess Graft as Pivotal Trials Advance Toward Commercialization
9d ago
XELTI
Xeltis Plans Relocation to High Tech Campus Eindhoven to Support Commercial Scale-Up
Premium
Private Companies
Xeltis Plans Relocation to High Tech Campus Eindhoven to Support Commercial Scale-Up
11d ago
XELTI
Xeltis Plans Relocation to High Tech Campus Eindhoven to Support Growth and Commercialization
PremiumPrivate Companies
Xeltis Plans Relocation to High Tech Campus Eindhoven to Support Growth and Commercialization
11d ago
XELTI
Xeltis Gains Investor-Facing Exposure at BioCapital Europe Cardiovascular Panel
PremiumPrivate Companies
Xeltis Gains Investor-Facing Exposure at BioCapital Europe Cardiovascular Panel
17d ago
XELTI
Xeltis Showcases Cardiovascular MedTech Focus at BioCapital Europe
PremiumPrivate Companies
Xeltis Showcases Cardiovascular MedTech Focus at BioCapital Europe
17d ago
XELTI
Xeltis Intensifies Conference Outreach as aXess Vascular Access Candidate Nears Commercial Stage
PremiumPrivate Companies
Xeltis Intensifies Conference Outreach as aXess Vascular Access Candidate Nears Commercial Stage
24d ago
XELTI
Xeltis Steps Up Conference Engagement as aXess Advances Toward Commercialization
PremiumPrivate CompaniesXeltis Steps Up Conference Engagement as aXess Advances Toward Commercialization
24d ago
XELTI
Xeltis Advances aXess Hemodialysis Clinical Program With Serbian Trial Site
Premium
Private Companies
Xeltis Advances aXess Hemodialysis Clinical Program With Serbian Trial Site
29d ago
XELTI
Xeltis Advances aXess Hemodialysis Clinical Program With Serbian Trial Site
Premium
Private Companies
Xeltis Advances aXess Hemodialysis Clinical Program With Serbian Trial Site
29d ago
XELTI
Xeltis Highlights First aXess Implantation at Maastricht University Medical Center
PremiumPrivate Companies
Xeltis Highlights First aXess Implantation at Maastricht University Medical Center
1M ago
XELTI
Xeltis Highlights First aXess Implantation at Maastricht University Medical Center
PremiumPrivate Companies
Xeltis Highlights First aXess Implantation at Maastricht University Medical Center
1M ago
XELTI
Xeltis Highlights First aXess Implantation at Maastricht University Medical Center
PremiumPrivate Companies
Xeltis Highlights First aXess Implantation at Maastricht University Medical Center
1M ago
XELTI
Xeltis Highlights First aXess Implantation at Maastricht University Medical Center
PremiumPrivate Companies
Xeltis Highlights First aXess Implantation at Maastricht University Medical Center
1M ago
XELTI
Xeltis Showcases aXess Clinical Progress at Nephrology Scientific Meeting
PremiumPrivate CompaniesXeltis Showcases aXess Clinical Progress at Nephrology Scientific Meeting
1M ago
XELTI
Xeltis Showcases aXess Clinical Progress at Key Nephrology Meeting
Premium
Private Companies
Xeltis Showcases aXess Clinical Progress at Key Nephrology Meeting
1M ago
XELTI
Xeltis Showcases aXess Clinical Progress at Nephrology Conference
Premium
Private Companies
Xeltis Showcases aXess Clinical Progress at Nephrology Conference
1M ago
XELTI

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >